跳至主要内容
临床试验/EUCTR2019-000171-16-GB
EUCTR2019-000171-16-GB进行中(未招募)1 期

Comparison between Propofol and Inhalational Anaesthetic Agents on Cardiovascular Outcomes following Cardiac Surgery - a Randomised Controlled Feasibility Trial - COPIA

King's College Hospital NHS Foundation Trust0 个研究点目标入组 50 人开始时间: 2019年7月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Patients (male and female) aged 18 years and above
  • 2.Written informed consent to participate
  • 3.Patients undergoing Coronary Artery Bypass Graft (CABG) surgery on Cardiopulmonary bypass (CPB) with or without valve surgery
  • 4. Additive European System for Cardiac Operative Risk Evaluation (EuroSCORE) of 5 or higher (higher scores indicating a greater risk of death; 0 indicates minimum risk and =6 indicates high risk)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 50

排除标准

  • 1.Pregnant or lactating women
  • 2.Allergy to propofol
  • 3.Previous diagnosis or suspected malignant hyperthermia
  • 4. Patients with a known sensitivity to any of the IMPs or other halogenated anaesthetics
  • 5. Concomitant therapy with Glibenclamide, Allopurinol, Theophylline or Nicorandil (medications that may interfere with remote ischemic preconditioning)
  • 6. Inclusion in another clinical trial of an investigational medicinal product within the last 3 months.

研究者

相似试验